Alpha DNA Investment Management’s Inspire Medical Systems INSP Stock Holding History

Alpha DNA Investment Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,275	Closed	-$1M	–	192
2023 Q1	$1M	Buy	+4,275	New	+$1.08M	0.3%	119
2021 Q2	–	Sell	-6	Closed	-$1K	–	354
2021 Q1	$1K	Sell	6 -10	-63%	-$2.13K	﹤0.01%	625
2020 Q4	$3K	Buy	+16	New	+$2.62K	﹤0.01%	417

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Alpha DNA Investment Management's INSP Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 4,275 shares — an estimated $1M sold.

Alpha DNA Investment Management first reported a position in INSP in Q4 2020 and held it in 3 quarters. The position peaked at $1M in Q1 2023. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

Alpha DNA Investment Management reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
Alpha DNA Investment Management sold 4,275 Inspire Medical Systems shares in Q2 2023, an estimated $1M.
Alpha DNA Investment Management first reported a position in Inspire Medical Systems in Q4 2020 and held it in 3 quarters.
Alpha DNA Investment Management's Inspire Medical Systems position peaked at $1M in Q1 2023.
407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.